secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innovation1 Biotech Inc. (—)
CIK:        0001629205
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001753926-25-000312
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innovation1 Biotech appoints Samuel Knipper as CFO and interim CEO
------------------------------------------------------------------

- Samuel Knipper, 30, appointed CFO effective Feb 23, 2025; also named interim CEO under Brio agreement.
- Knipper designated by Brio Financial Group; company pays Brio $8,500/month plus expenses for controller and reporting services.
- Appointment lasts approximately 120 days or until close of a SPAC merger or exchange listing, whichever comes first.
- Knipper previously senior associate at Calabrese Consulting and SEC reporting manager at Brio Financial Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1629205/000175392625000312/0001753926-25-000312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1629205/000175392625000312/g084715_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer